Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
X-linked Traits01:19

X-linked Traits

In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot Evaluation of the Biopsychosocial Screening Inventory for Fragile X Syndrome (BIPSSI-FX) with an Extended African American Family.

Journal of theory construction & testing·2026
Same author

Upholding Pluralism in Occupational Therapy: A Response to Recent Calls for Political Alignment.

Canadian journal of occupational therapy. Revue canadienne d'ergotherapie·2026
Same author

Antiracist mental healthcare training and development of multicultural awareness, knowledge and skills among school mental health providers in Canada.

Transcultural psychiatry·2025
Same author

Cascade testing in an ovarian cancer traceback genetic testing program: The GRACE study experience.

Journal of genetic counseling·2025
Same author

Patient-initiated lifestyle changes following receipt of genetic test results in a predominantly marginalized population.

Journal of genetic counseling·2025
Same author

Primary care patient and clinician attitudes about population genomic screening, informed decision-making needs, and the potential for Chatbot technology.

Journal of genetic counseling·2025

Related Experiment Video

Updated: May 25, 2026

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
08:22

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene

Published on: September 16, 2019

Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts.

Jessica Ezzell Hunter1, Stephanie Sherman, Jim Grigsby

  • 1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Neuropsychology
|January 19, 2012
PubMed
Summary

Male carriers of the FMR1 premutation allele without FXTAS show no global executive function deficits. However, some carriers may have impaired inhibitory capacity, unrelated to age or repeat length.

More Related Videos

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
11:10

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation

Published on: July 6, 2022

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
09:46

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

Related Experiment Videos

Last Updated: May 25, 2026

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
08:22

A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene

Published on: September 16, 2019

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
11:10

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation

Published on: July 6, 2022

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
09:46

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP

Published on: January 24, 2025

Area of Science:

  • Neurogenetics
  • Cognitive Neuroscience
  • Fragile X-associated Disorders

Background:

  • The FMR1 premutation allele (55-200 CGG repeats) is associated with various neurological conditions.
  • Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting male carriers.
  • Neuropsychological profiles in male carriers without FXTAS are not fully understood.

Purpose of the Study:

  • To investigate the neuropsychological profile, specifically executive function, in male carriers of the FMR1 premutation allele who do not meet criteria for FXTAS.
  • To compare executive function performance between male carriers and non-carriers.

Main Methods:

  • A multicenter collaboration involving 3 independent cohorts.
  • 100 male carriers of the FMR1 premutation allele and 216 non-carriers participated.
  • Standardized executive function tests were administered, including the Stroop Color-Word Test, Hayling Sentence Completion Test Part B, and Behavioral Dyscontrol Scale, with statistical models adjusting for cohort, age, and education.

Main Results:

  • Male carriers scored significantly lower than non-carriers on the Stroop Color-Word Test, Hayling Sentence Completion Test Part B, and Behavioral Dyscontrol Scale.
  • The Hayling test showed a significant age-related decline in carriers.
  • No specific age groups or repeat length ranges within the premutation were associated with increased risk for executive function deficits.

Conclusions:

  • Preliminary findings suggest no global executive function impairment in male FMR1 premutation carriers without FXTAS.
  • A subset of carriers may exhibit impaired inhibitory capacity.
  • Risk factors for this potential impairment do not appear to be linked to age or FMR1 repeat length.